» Articles » PMID: 33097710

USP52 Regulates DNA End Resection and Chemosensitivity Through Removing Inhibitory Ubiquitination from CtIP

Overview
Journal Nat Commun
Specialty Biology
Date 2020 Oct 24
PMID 33097710
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Human C-terminal binding protein (CtBP)-interacting protein (CtIP) is a central regulator to initiate DNA end resection and homologous recombination (HR). Several studies have shown that post-translational modifications control the activity or expression of CtIP. However, it remains unclear whether and how cells restrain CtIP activity in unstressed cells and activate CtIP when needed. Here, we identify that USP52 directly interacts with and deubiquitinates CtIP, thereby promoting DNA end resection and HR. Mechanistically, USP52 removes the ubiquitination of CtIP to facilitate the phosphorylation and activation of CtIP at Thr-847. In addition, USP52 is phosphorylated by ATM at Ser-1003 after DNA damage, which enhances the catalytic activity of USP52. Furthermore, depletion of USP52 sensitizes cells to PARP inhibition in a CtIP-dependent manner in vitro and in vivo. Collectively, our findings reveal the key role of USP52 and the regulatory complexity of CtIP deubiquitination in DNA repair.

Citing Articles

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT.

Liu J, Luo Y, Chen S, Wang G, Jin W, Jiang W Adv Sci (Weinh). 2024; 11(45):e2403995.

PMID: 39392373 PMC: 11615784. DOI: 10.1002/advs.202403995.


VGLL3 modulates chemosensitivity through promoting DNA double-strand break repair.

Wu W, Fan Z, Fu H, Ma X, Wang D, Liu H Sci Adv. 2024; 10(41):eadr2643.

PMID: 39383226 PMC: 11463272. DOI: 10.1126/sciadv.adr2643.


Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer.

Xie Y, Xiao D, Li D, Peng M, Peng W, Duan H Front Oncol. 2024; 14:1441222.

PMID: 39156700 PMC: 11327142. DOI: 10.3389/fonc.2024.1441222.


C-Terminal Binding Protein: Regulator between Viral Infection and Tumorigenesis.

Huang M, Li Y, Li Y, Liu S Viruses. 2024; 16(6).

PMID: 38932279 PMC: 11209466. DOI: 10.3390/v16060988.


Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.

Gao H, Xi Z, Dai J, Xue J, Guan X, Zhao L Mol Cancer. 2024; 23(1):88.

PMID: 38702734 PMC: 11067278. DOI: 10.1186/s12943-024-02005-y.


References
1.
Wang H, Shao Z, Shi L, Hwang P, Truong L, Berns M . CtIP protein dimerization is critical for its recruitment to chromosomal DNA double-stranded breaks. J Biol Chem. 2012; 287(25):21471-80. PMC: 3375568. DOI: 10.1074/jbc.M112.355354. View

2.
Liu H, Zhang H, Wang X, Tian Q, Hu Z, Peng C . The Deubiquitylating Enzyme USP4 Cooperates with CtIP in DNA Double-Strand Break End Resection. Cell Rep. 2015; 13(1):93-107. DOI: 10.1016/j.celrep.2015.08.056. View

3.
Peng Y, Liao Q, Tan W, Peng C, Hu Z, Chen Y . The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors. Nat Commun. 2019; 10(1):1224. PMC: 6420636. DOI: 10.1038/s41467-019-09232-8. View

4.
Yang S, Liu L, Cao C, Song N, Wang Y, Ma S . USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization. Nat Commun. 2018; 9(1):1285. PMC: 5876348. DOI: 10.1038/s41467-018-03588-z. View

5.
Mertins P, Qiao J, Patel J, Udeshi N, Clauser K, Mani D . Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods. 2013; 10(7):634-7. PMC: 3943163. DOI: 10.1038/nmeth.2518. View